PRAX
Price
$69.93
Change
-$0.09 (-0.13%)
Updated
Nov 5, 11:55 AM (EDT)
One day until earnings call
STRO
Price
$3.76
Change
+$0.07 (+1.90%)
Updated
Nov 5, 12:09 PM (EDT)
2 days until earnings call
Ad is loading...

PRAX vs STRO

Header iconPRAX vs STRO Comparison
Open Charts PRAX vs STROBanner chart's image
Praxis Precision Medicines
Price$69.93
Change-$0.09 (-0.13%)
Volume$100
CapitalizationN/A
Sutro Biopharma
Price$3.76
Change+$0.07 (+1.90%)
Volume$300
CapitalizationN/A
View a ticker or compare two or three
PRAX vs STRO Comparison Chart
Loading...
PRAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
PRAX vs. STRO commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRAX is a Hold and STRO is a Buy.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (PRAX: $69.99 vs. STRO: $3.69)
Brand notoriety: PRAX and STRO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRAX: 70% vs. STRO: 130%
Market capitalization -- PRAX: $1.24B vs. STRO: $302.45M
PRAX [@Biotechnology] is valued at $1.24B. STRO’s [@Biotechnology] market capitalization is $302.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRAX’s FA Score shows that 0 FA rating(s) are green whileSTRO’s FA Score has 1 green FA rating(s).

  • PRAX’s FA Score: 0 green, 5 red.
  • STRO’s FA Score: 1 green, 4 red.
According to our system of comparison, STRO is a better buy in the long-term than PRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRAX’s TA Score shows that 4 TA indicator(s) are bullish while STRO’s TA Score has 5 bullish TA indicator(s).

  • PRAX’s TA Score: 4 bullish, 4 bearish.
  • STRO’s TA Score: 5 bullish, 1 bearish.
According to our system of comparison, STRO is a better buy in the short-term than PRAX.

Price Growth

PRAX (@Biotechnology) experienced а -2.43% price change this week, while STRO (@Biotechnology) price change was +3.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +14.28%, and the average quarterly price growth was +9.89%.

Reported Earning Dates

PRAX is expected to report earnings on Mar 12, 2025.

STRO is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRAX($1.24B) has a higher market cap than STRO($302M). PRAX YTD gains are higher at: 214.138 vs. STRO (-13.986). STRO has higher annual earnings (EBITDA): -63.93M vs. PRAX (-132.26M). STRO has more cash in the bank: 426M vs. PRAX (352M). PRAX has less debt than STRO: PRAX (1.95M) vs STRO (26.5M). STRO has higher revenues than PRAX: STRO (169M) vs PRAX (1.77M).
PRAXSTROPRAX / STRO
Capitalization1.24B302M412%
EBITDA-132.26M-63.93M207%
Gain YTD214.138-13.986-1,531%
P/E RatioN/AN/A-
Revenue1.77M169M1%
Total Cash352M426M83%
Total Debt1.95M26.5M7%
FUNDAMENTALS RATINGS
STRO: Fundamental Ratings
STRO
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRAXSTRO
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 12 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
N/A
View a ticker or compare two or three
Ad is loading...
PRAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
STRO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRKZX8.040.04
+0.50%
PGIM Real Estate Income Z
TEURX25.000.08
+0.32%
Franklin Mutual International Value C
FGGGX37.760.09
+0.24%
American Funds Intl Gr and Inc529-F-2
PXEAX24.590.05
+0.20%
Impax Global Environmental Markets A
MVGBX17.670.01
+0.06%
MFS Low Volatility Global Equity B

PRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with INZY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
+2.43%
INZY - PRAX
38%
Loosely correlated
+1.38%
VERU - PRAX
35%
Loosely correlated
-4.39%
ZYME - PRAX
34%
Loosely correlated
+11.14%
STRO - PRAX
33%
Poorly correlated
+3.94%
CLRB - PRAX
32%
Poorly correlated
N/A
More

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with INZY. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
+3.94%
INZY - STRO
46%
Loosely correlated
+1.38%
STOK - STRO
45%
Loosely correlated
+1.87%
NUVB - STRO
45%
Loosely correlated
-0.43%
ALGS - STRO
44%
Loosely correlated
-1.36%
AVIR - STRO
42%
Loosely correlated
+1.52%
More